Related Experiment Video
Updated: Jun 26, 2026

One-step Negative Chromatographic Purification of Helicobacter pylori Neutrophil-activating Protein Overexpressed in Escherichia coli in Batch Mode
Published on: June 18, 2016
Oxidative stress-induced peptidoglycan deacetylase in Helicobacter pylori
Ge Wang1, Adriana Olczak, Lennart S Forsberg
1Department of Microbiology, University of Georgia, Athens, Georgia 30602, USA.
Abstract:
Structural modification of peptidoglycan (PG) is one of the mechanisms that pathogenic bacteria use to evade the host innate immune system. For the noninvasive human gastric pathogen Helicobacter pylori, PG delivery to the host cells is one trigger of the immune response. H. pylori HP310 was markedly up-expressed upon cell exposure to oxidative stress. However, disruption of HP310 did not produce a phenotype distinguishable from the parent, including oxidative stress resistance characteristics. HP310 shows very weak homology to a known gene pgdA encoding PG deacetylase in Streptococcous pneumoniae. PGs from wild type H. pylori and the HP310 mutant were purified and analyzed by matrix-assisted laser desorption ionization time-of-flight and high pressure liquid chromatography. The parent strain PG is partially deacetylated, whereas several major PG-deacetylated muropeptides are absent or significantly reduced in the HP310 mutant. PG deacetylase activity was directly demonstrated by use of pure PG and HP310 protein by measuring the release of acetic acid. The Gram-negative bacterium H. pylori is highly resistant to lysozyme (up to 50 mg/ml), but the HP310 mutant is less resistant to lysozyme compared with the parent strain. Complementation of an hp310 strain with the wild type gene restored lysozyme resistance. The purified PG from the mutant is more susceptible to lysozyme (0.3 mg/ml) digestion than the wild type PG. The PG deacetylation appears to confer lysozyme resistance to escape immune detection. HP310 is representative of a new subfamily of bacterial PG deacetylases.
Insights
Helicobacter pylori HP310 protein deacetylates peptidoglycan, increasing resistance to lysozyme and immune evasion. This discovery identifies a new subfamily of bacterial peptidoglycan deacetylases.
Area of Science:
- Microbiology
- Bacterial Pathogenesis
- Immunology
Background:
- Pathogenic bacteria modify peptidoglycan (PG) to evade host immunity.
- Helicobacter pylori delivers PG to host cells, triggering immune responses.
- HP310, a gene in H. pylori, is upregulated by oxidative stress.
Purpose of the Study:
- To investigate the function of H. pylori HP310 in peptidoglycan modification and immune evasion.
- To characterize the enzymatic activity of HP310.
- To determine the role of HP310 in lysozyme resistance.
Main Methods:
- Purification and analysis of peptidoglycan from wild-type and HP310 mutant H. pylori strains using MALDI-TOF and HPLC.
- Enzymatic assays measuring acetic acid release from pure PG using HP310 protein.
- Lysozyme susceptibility assays on purified PG and whole bacterial cells.
Main Results:
- HP310 mutant H. pylori showed reduced PG deacetylation compared to the wild type.
- HP310 protein demonstrated direct peptidoglycan deacetylase activity.
- HP310 mutant strains exhibited decreased resistance to lysozyme digestion.
- Complementation with wild-type HP310 restored lysozyme resistance.
Conclusions:
- HP310 is a novel peptidoglycan deacetylase essential for H. pylori lysozyme resistance.
- Peptidoglycan deacetylation by HP310 contributes to immune evasion.
- HP310 represents a new subfamily of bacterial PG deacetylases.
More Related Videos
Related Concept Videos
Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Gastritis II: Pathophysiology
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...

